The healthcare sector has grown strongly in recent years, particularly as the global pandemic reinforced the importance of healthcare worldwide. As a result, there has been an increased focus amongst investors looking to back ambitious businesses within the sector.

Our Partner, Phil Frame sat down with MedTech News and shared why MedTech and medical device companies should take advantage of growing interest from investors.

Phil shared his thoughts on how the pandemic has caused a shift in consumer behaviour across several industries, while technology has remained pivotal to keeping businesses agile and is pioneering the way for future change. This is especially true within healthcare, where there are unprecedented levels of demand for tech-based services that are accelerating innovation in the sector.

Most notably, technology has supported the shift to a more remote-based system of healthcare, using data to derive personal treatments. The tech has encouraged a ‘patient-centric’ operating model, where patients can access healthcare professionals through the most convenient means to them, whether that’s face-to-face, virtual, remote, or even digital care.

From an investment point of view, the MedTech industry is flourishing, attracting interest from major players around the world. Global investors completed a record-breaking 96 deals in the subsector in 2021 and with this, deal value has surged to $40.8 billion.

Without question, the MedTech industry continues to be an attractive proposition for investors like NorthEdge, who work alongside management teams to build better businesses, together.

Visit the article on here to read more here.